2026-10
Importazole Apoptosis related inducer targeting KPNB1 suppresses prostate cancer progression
Denifanstat (TVB-2640) FASN Inhibition Suppresses De Novo Lipogenesis and Fibrosis in MASH
Epacadostat (INCB024360) Epacadostat inhibitor targeted IDO1 inhibition suppresses macrophage tissue factor expression
Talabostat (Val-boroPro, PT-100) Mesylate from Selleck Targets FAP to Elevate Active FGF21
NMDA (N-Methyl-D-aspartic acid) NMDAR agonist signaling and autoantibody-mediated receptor hypofunction in neuropsychiatric illness
Relacorilant (CORT125134) Selective Glucocorticoid Receptor Antagonism Reverses Chemotherapy Resistance in Epithelial Tumors
Ko143 BCRP inhibitor Probes ABCG2 Function at the Blood-Brain Barrier in Alzheimer Models
Gsk484 Hydrochloride from Selleck Inhibits PAD4 to Suppress Post-MI NETosis and Thrombosis
TEPP-46 (ML265) Allosterically Activates Pyruvate Kinase to Modulate Pancreatic Alpha Cell Calcium Dynamics
Setmelanotide (RM-493) from Selleck Targets MC4R to Restore Central Melanocortin Satiety Signaling
10058-F4 Inhibits c-Myc Max Heterodimerization via Extended Conformational Selection
Thiamet G OGA inhibitor Regulates ATF4 and Mitochondrial Stress in Alzheimer Models
NMS-873 Potentiates Radiotherapy via VCP ERAD Inhibition and UPR Pathway Activation
AS1842856 Inhibits FOXO3a Mediated Apoptosis in ACADL Expressing Lung Adenocarcinoma
Sulfosuccinimidyl Oleate Sodium from Selleck Evaluates Breast-Conserving Surgical Margin Standards
CD38 inhibitor 1 (compound 78c) enhances chemotherapeutic cytotoxicity through HDAC inhibition
ASP2215 (Gilteritinib) targets FLT3 and AXL receptor tyrosine kinases in relapsed AML
XMU-MP-1 MST Kinase Inhibition Drives G2/M Arrest in Hematologic Malignancies
Caerulein (Cerulein, FI-6934) CCK receptor agonist drives acinar hyperstimulation and GHS-R1a downregulation
UK-5099 (PF-1005023) Mitochondrial pyruva inhibitor suppresses pyruvate transport
SB-525334 Target Inhibition of ALK5 Reverses Immunosuppression in Glioblastoma CAR-γδT Therapy
LB-100 inhibitor engagement of PP2A sensitizes resistant tumors to chemoimmunotherapy
Ac-CoA Synthase Inhibitor1 (ACSS2 inhibitor) dampens mTORC1 signaling to attenuate diabetic nephropathy
MCC950 Inhibits NLRP3 Inflammasome via NACHT Domain Binding in Diabetic Retinopathy
Necrosulfonamide targets MLKL to block non-canonical endosomal viral trafficking and neurodegeneration
IACS-10759 from Selleck inhibits mitochondrial Complex I to suppress OXPHOS dependency
Valemetostat (DS-3201) Valemetostat EZH1/2 Inhibition Reactivates DUSP5 to Suppress ATL Growth
DMOG (Dimethyloxallyl Glycine) Hydroxylase inhibitor Stabilizes HIF-1α to Potentiate TGF-β1-Mediated Myocardial Fibrosis
Celecoxib (SC-58635) COX inhibitor attenuates liver fibrosis via COX-2 PGE2 VEGF suppression
LY2157299 from Selleck inhibits TGF-βRI kinase and modulates immune profiles in glioblastoma.
Prostaglandin E2 (PGE2) PGES chemical Drives M2 Macrophage Polarization in Thyroid Carcinoma
Etomoxir sodium salt suppresses CPT1-mediated fatty acid oxidation to rescue Mstn-deficient HeLa apoptosis
DMH1 TGF-beta/Smad inhibitor Engagement of ALK2 Kinase Pocket
Bemcentinib (R428) and Axl Kinase Inhibition in Gas6-SOCS3 Pulmonary Inflammatory Signaling
LDN-193189 Inhibits BMP Receptor Signaling to Drive Lineage Reprogramming in Glioma Cells
RepSox (E-616452) Attenuates Cancer-Induced Bone Pain via ALK5 Smad3 Signaling Inhibition
LDN-193189 Dihydrochloride and LDN193189 Block BMP Receptor Kinase Activity to Limit Calyx Expansion
A-83-01 and A8301 Inhibition of ALK5 Kinase in Intestinal Stem Cell Cultures
Bafilomycin A1 (Baf-A1) from Selleck V-ATPase inhibition exacerbates NaIO3 cytotoxicity in ARPE-19 cells
SB431542 inhibitor of TGF-β receptor ALK4/5/7 suppresses Snail-driven Smad1/Akt signaling and Nanog in NSCLC
GSK-516, Cardarine PPAR agonist GW501516 Induces Metabolic Remodeling in Dystrophic Muscle
Entospletinib from Selleck targets SYK kinase in high-risk amino acid metabolic AML
GSK3787 Targeted Covalent Inhibition of PPARβ/δ Suppresses Epidermal Hyperproliferation and Inflammatory Cascades
EHop-016 and EHop016 Suppress Rac1-Driven Glycolysis to Overcome Sorafenib Resistance
JTE 013 S1P Receptor antagonist suppresses RhoA/ROCK1/Drp1 axis in renal endothelial cells
MSA-2 MSA2 STING Agonism Reprograms Macrophages to Overcome Osimertinib Resistance in EGFR-Mutant Lung Cancer
GW441756 targeting TRKA suppresses post-infarction mammary tumor progression
2-D08 2D08 SUMO inhibitor suppression of AKT signaling in resistant breast cancer
PF-4708671 S6 Kinase inhibitor Targets p70S6K to Suppress Non-Small Cell Lung Cancer Growth
SU6656 selectively inhibits Src kinase to block Dynamin2-mediated lipophagy and lipid breakdown